Kayne Anderson Rudnick Investment Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-52
Closed -$1K 629
2022
Q1
$1K Buy
+52
New +$1K ﹤0.01% 629